Sanofi (ENXTPA:SAN): Revisiting Valuation After a Recent Share Price Rebound [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
This invites a closer look at what the market is currently pricing in. See our latest analysis for Sanofi. The recent uptick, alongside a 90 day share price return of 3.42% and a milder 1 year total shareholder return of negative 6.44%, suggests sentiment is stabilising rather than surging as investors weigh steady earnings growth against past regulatory and pipeline worries. If Sanofi's move has you reassessing healthcare defensives, this could be a good moment to explore other healthcare stocks that might offer a different balance of growth and resilience. With earnings still growing, a solid dividend track record and the share price trading at a steep discount to analyst targets, is Sanofi now a mispriced defensive buy, or is the market already discounting future growth? With Sanofi last closing at €82.22 against a narrative fair value of about €105.20, the valuation hinges on steady growth, fatter margins, and disciplined capital use. Sanofi's ongoing focus on innovati
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Sanofi to Buy Dynavax to Boost Vaccines Business [Yahoo! Finance]Yahoo! Finance
- What Sanofi Is Getting Through The Acquisition Of Dynavax [Seeking Alpha]Seeking Alpha
- Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise [Yahoo! Finance]Yahoo! Finance
- BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax [Yahoo! Finance]Yahoo! Finance
- BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax [Yahoo! Finance Canada]Yahoo! Finance Canada
SNY
Sec Filings
- 12/23/25 - Form 6-K
- 12/22/25 - Form 6-K
- 12/15/25 - Form 6-K
- SNY's page on the SEC website